BR0104351A - Taxanos substituìdos com carbonato c7 como agentes antitumor - Google Patents

Taxanos substituìdos com carbonato c7 como agentes antitumor

Info

Publication number
BR0104351A
BR0104351A BR0104351-0A BR0104351A BR0104351A BR 0104351 A BR0104351 A BR 0104351A BR 0104351 A BR0104351 A BR 0104351A BR 0104351 A BR0104351 A BR 0104351A
Authority
BR
Brazil
Prior art keywords
taxanes
carbonate
substituted
antitumor agents
agents
Prior art date
Application number
BR0104351-0A
Other languages
English (en)
Inventor
Robert A Holton
Original Assignee
Univ Florida State Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Florida State Res Found filed Critical Univ Florida State Res Found
Publication of BR0104351A publication Critical patent/BR0104351A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D305/00Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

Patente de Invenção: "TAXANOS SUBSTITUìDOS COM CARBONATO C7 COMO AGENTES ANTITUMOR". Taxanos tendo um substituinte de carbonato em C(7), um substituinte de hidróxi em C(10) e uma faixa de substituintes com cadeia lateral e C(2), C(9) e C(14).
BR0104351-0A 2000-02-02 2001-02-02 Taxanos substituìdos com carbonato c7 como agentes antitumor BR0104351A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17967100P 2000-02-02 2000-02-02
PCT/US2001/003554 WO2001057030A1 (en) 2000-02-02 2001-02-02 C7 carbonate substituted taxanes as antitumor agents

Publications (1)

Publication Number Publication Date
BR0104351A true BR0104351A (pt) 2002-01-02

Family

ID=22657501

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0104351-0A BR0104351A (pt) 2000-02-02 2001-02-02 Taxanos substituìdos com carbonato c7 como agentes antitumor

Country Status (25)

Country Link
US (3) US6780879B2 (pt)
EP (1) EP1165552A1 (pt)
JP (1) JP2003522170A (pt)
KR (1) KR20010112395A (pt)
CN (1) CN1362958A (pt)
AU (1) AU776122B2 (pt)
BG (1) BG64890B1 (pt)
BR (1) BR0104351A (pt)
CA (1) CA2368540A1 (pt)
CZ (1) CZ20013429A3 (pt)
GE (1) GEP20043226B (pt)
HK (1) HK1047934A1 (pt)
HU (1) HUP0200756A3 (pt)
IL (1) IL145637A0 (pt)
MX (1) MXPA01009906A (pt)
NO (1) NO20014755L (pt)
NZ (1) NZ514380A (pt)
PL (1) PL350315A1 (pt)
RO (1) RO121271B1 (pt)
RU (1) RU2265019C2 (pt)
SK (1) SK13702001A3 (pt)
TR (1) TR200102857T1 (pt)
UA (1) UA74331C2 (pt)
WO (1) WO2001057030A1 (pt)
ZA (1) ZA200108051B (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6649632B2 (en) * 2000-02-02 2003-11-18 Fsu Research Foundation, Inc. C10 ester substituted taxanes
US6780879B2 (en) * 2000-02-02 2004-08-24 Fsu Research Foundation, Inc. C7 carbonate substituted taxanes
CN100522955C (zh) * 2002-08-02 2009-08-05 伊缪诺金公司 含有新型强效紫杉烷的细胞毒性剂及其治疗用途
US7390898B2 (en) 2002-08-02 2008-06-24 Immunogen Inc. Cytotoxic agents containing novel potent taxanes and their therapeutic use
PE20050693A1 (es) * 2004-02-13 2005-09-27 Univ Florida State Res Found Taxanos sustituidos con esteres de ciclopentilo en c10
JP2008530122A (ja) * 2005-02-14 2008-08-07 フロリダ・ステイト・ユニバーシティ・リサーチ・ファウンデイション・インコーポレイテッド C10シクロプロピルエステル置換タキサン組成物
CA2718567A1 (en) * 2008-03-31 2009-12-03 Florida State University Research Foundation, Inc. C(10) ethyl ester and c(10) cyclopropyl ester substituted taxanes

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2601675B1 (fr) * 1986-07-17 1988-09-23 Rhone Poulenc Sante Derives du taxol, leur preparation et les compositions pharmaceutiques qui les contiennent
US5175315A (en) 1989-05-31 1992-12-29 Florida State University Method for preparation of taxol using β-lactam
MX9102128A (es) 1990-11-23 1992-07-08 Rhone Poulenc Rorer Sa Derivados de taxano,procedimiento para su preparacion y composicion farmaceutica que los contiene
US5283253A (en) 1991-09-23 1994-02-01 Florida State University Furyl or thienyl carbonyl substituted taxanes and pharmaceutical compositions containing them
US5227400A (en) 1991-09-23 1993-07-13 Florida State University Furyl and thienyl substituted taxanes and pharmaceutical compositions containing them
US5714513A (en) 1991-09-23 1998-02-03 Florida State University C10 taxane derivatives and pharmaceutical compositions
US5243045A (en) 1991-09-23 1993-09-07 Florida State University Certain alkoxy substituted taxanes and pharmaceutical compositions containing them
US5721268A (en) 1991-09-23 1998-02-24 Florida State University C7 taxane derivatives and pharmaceutical compositions containing them
US5430160A (en) 1991-09-23 1995-07-04 Florida State University Preparation of substituted isoserine esters using β-lactams and metal or ammonium alkoxides
US5350866A (en) 1991-09-23 1994-09-27 Bristol-Myers Squibb Company 10-desacetoxytaxol derivatives
DE69329304T2 (de) 1992-01-15 2001-01-04 Squibb & Sons Inc Enzymatische Verfahren zur Resolution von Enantiomeren-Mischungen nützlich wie Zwischenprodukte zur Herstellung von Taxanen
FR2687150B1 (fr) 1992-02-07 1995-04-28 Rhone Poulenc Rorer Sa Procede de preparation de derives du taxane.
US5272171A (en) 1992-02-13 1993-12-21 Bristol-Myers Squibb Company Phosphonooxy and carbonate derivatives of taxol
US5698712A (en) 1992-03-06 1997-12-16 Indena S.P.A. Baccatine III derivatives
US5939561A (en) 1992-03-10 1999-08-17 Rhone-Poulence Rorer S.A. Process for the preparation of β-phenylisoserine and β-lactam and their analogues
US5470866A (en) 1992-08-18 1995-11-28 Virginia Polytechnic Institute And State University Method for the conversion of cephalomannine to taxol and for the preparation of n-acyl analogs of taxol
US5319112A (en) 1992-08-18 1994-06-07 Virgnia Tech Intellectual Properties, Inc. Method for the conversion of cephalomannine to taxol and for the preparation of N-acyl analogs of taxol
MX9307777A (es) * 1992-12-15 1994-07-29 Upjohn Co 7-HALO-Y 7ß, 8ß-METANO-TAXOLES, USO ANTINEOPLASTICO Y COMPOSICIONES FARMACEUTICAS QUE LOS CONTIENEN.
CA2111527C (en) 1992-12-24 2000-07-18 Jerzy Golik Phosphonooxymethyl ethers of taxane derivatives
EP1260507A1 (en) * 1993-02-05 2002-11-27 Bryn Mawr College Synthesis of taxol, analogs and intermediates with variable A-nng side chains
US5703247A (en) 1993-03-11 1997-12-30 Virginia Tech Intellectual Properties, Inc. 2-Debenzoyl-2-acyl taxol derivatives and methods for making same
US5475011A (en) 1993-03-26 1995-12-12 The Research Foundation Of State University Of New York Anti-tumor compounds, pharmaceutical compositions, methods for preparation thereof and for treatment
EP0703909B1 (en) 1993-06-11 2000-04-26 PHARMACIA & UPJOHN COMPANY Delta 6,7 -taxols antineoplastic use and pharmaceutical compositions containing them
IL109926A (en) 1993-06-15 2000-02-29 Bristol Myers Squibb Co Methods for the preparation of taxanes and microorganisms and enzymes utilized therein
TW397866B (en) 1993-07-14 2000-07-11 Bristol Myers Squibb Co Enzymatic processes for the resolution of enantiomeric mixtures of compounds useful as intermediates in the preparation of taxanes
CA2129288C (en) 1993-08-17 2000-05-16 Jerzy Golik Phosphonooxymethyl esters of taxane derivatives
FR2711369B1 (fr) 1993-10-20 1995-11-17 Rhone Poulenc Rorer Sa Nouveaux taxoïdes, leur préparation et les compositions qui les contiennent.
US5824701A (en) * 1993-10-20 1998-10-20 Enzon, Inc. Taxane-based prodrugs
US5622986A (en) * 1993-10-20 1997-04-22 Enzon, Inc. 2'-and/or 7-substituted taxanes
AU4133096A (en) 1994-10-28 1996-05-23 Research Foundation Of The State University Of New York, The Taxoid derivatives, their preparation and their use as antitumor agents
US5801191A (en) 1995-06-01 1998-09-01 Biophysica Foundation Taxoids
TW354293B (en) 1995-06-06 1999-03-11 Bristol Myers Squibb Co Prodrugs of paclitaxel derivatives
US5780653A (en) 1995-06-07 1998-07-14 Vivorx Pharmaceuticals, Inc. Nitrophenyl, 10-deacetylated substituted taxol derivatives as dual functional cytotoxic/radiosensitizers
WO1997009979A1 (en) 1995-09-13 1997-03-20 Florida State University Radiosensitizing taxanes and their pharmaceutical preparations
WO1997042181A1 (en) 1996-05-06 1997-11-13 Florida State University 1-deoxy baccatin iii, 1-deoxy taxol and 1-deoxy taxol analogs and method for the preparation thereof
US5811452A (en) 1997-01-08 1998-09-22 The Research Foundation Of State University Of New York Taxoid reversal agents for drug-resistance in cancer chemotherapy and pharmaceutical compositions thereof
US5912264A (en) 1997-03-03 1999-06-15 Bristol-Myers Squibb Company 6-halo-or nitrate-substituted paclitaxels
US7288665B1 (en) 1997-08-18 2007-10-30 Florida State University Process for selective derivatization of taxanes
US6780879B2 (en) 2000-02-02 2004-08-24 Fsu Research Foundation, Inc. C7 carbonate substituted taxanes
BR0104358A (pt) 2000-02-02 2002-01-02 Univ Florida State Res Found Formulações de taxana tendo solubilidade aperfeiçoada
US6638973B2 (en) * 2000-02-02 2003-10-28 Fsu Research Foundation, Inc. Taxane formulations
US6649632B2 (en) * 2000-02-02 2003-11-18 Fsu Research Foundation, Inc. C10 ester substituted taxanes
CN1186340C (zh) * 2000-02-02 2005-01-26 佛罗里达州立大学研究基金有限公司 用作抗肿瘤剂的c10碳酸酯取代的紫杉烷

Also Published As

Publication number Publication date
NO20014755L (no) 2001-11-29
HK1047934A1 (zh) 2003-03-14
EP1165552A1 (en) 2002-01-02
NZ514380A (en) 2005-03-24
US20050165051A1 (en) 2005-07-28
US6992104B2 (en) 2006-01-31
US20040138267A1 (en) 2004-07-15
NO20014755D0 (no) 2001-10-01
KR20010112395A (ko) 2001-12-20
GEP20043226B (en) 2004-04-26
UA74331C2 (uk) 2005-12-15
US20020065304A1 (en) 2002-05-30
AU3479301A (en) 2001-08-14
IL145637A0 (en) 2002-06-30
RU2265019C2 (ru) 2005-11-27
PL350315A1 (en) 2002-12-02
RO121271B1 (ro) 2007-02-28
ZA200108051B (en) 2003-12-01
US7226944B2 (en) 2007-06-05
SK13702001A3 (sk) 2002-06-04
CN1362958A (zh) 2002-08-07
HUP0200756A3 (en) 2005-02-28
HUP0200756A2 (hu) 2002-07-29
US6780879B2 (en) 2004-08-24
JP2003522170A (ja) 2003-07-22
MXPA01009906A (es) 2003-07-28
CA2368540A1 (en) 2001-08-09
BG64890B1 (bg) 2006-08-31
WO2001057030A1 (en) 2001-08-09
CZ20013429A3 (cs) 2002-04-17
BG105966A (en) 2002-07-31
AU776122B2 (en) 2004-08-26
TR200102857T1 (tr) 2002-06-21

Similar Documents

Publication Publication Date Title
BR0104749A (pt) Taxanos substituìdos com éster em c7 comoagentes antitumor
BR0104350A (pt) Taxanos de c10 acetato heterossubstituìdo como agentes antitumor
DK1414828T3 (da) Antitumoranaloger
BRPI0112375B8 (pt) aplidinas como derivados antitumorais
BR0104353A (pt) Taxanos heterosubstituìdos com acetato c7 como agentes antitumor
BR0105563A (pt) Derivados e análogos de galantamina
BR0104351A (pt) Taxanos substituìdos com carbonato c7 como agentes antitumor
BR0104779A (pt) Taxanos substituìdos com carbonato c10 comoagentes antitumor
DK0842165T3 (da) Thiazolidin-4-carboxylsyrederivater som cytobeskyttende midler
BR0104355A (pt) Taxanos substituìdos por c7 carbamoilóxi como agentes antitumor
BR0104352A (pt) Taxanos substituìdos por c10 carbamoilóxi como agentes antitumorais
BR0104354A (pt) Taxanos substituìdos com éster c10
BR0106789A (pt) Taxanos substituìdos com carbonato de c10
BR0106770A (pt) Taxanos substituìdos com éster de c7 éster
BR0106693A (pt) Taxanos substituìdos com éster de c10
UA33865A (uk) Дикалієва сіль n-сукцин - dl-триптофану, що має антиангінальну та антигіпоксантну дію
BR0109394A (pt) Compostos de esponja antitumores

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE 8A., 9A., 10A. E 11A. ANUIDADE(S).

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2138 DE 27/12/2011.